Serial #79403412
LIVE

Serial Number

79403412

Owner

Novartis AG

Attorney

Maury M. Tepper, III

Filing Date

May 28, 2024

Add to watchlist:

No watchlists yet
View on USPTO

Serial #79403412 Trademark

Serial Number: 79403412 • Registration: 8072574

Serial #79403412 is a trademark filed by Novartis AG on May 28, 2024. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

Novartis AG (12 trademarks)

CH-4002 Basel

Entity Type: 03

Trademark Details

Filing Date

May 28, 2024

Registration Date

December 23, 2025

Published for Opposition

November 4, 2025

Goods & Services

Anti-infectives; anti-inflammatories; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma

Filing History

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Mar 23, 2026 FICR
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Feb 12, 2026 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Jan 27, 2026 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Jan 27, 2026 OPNR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Dec 23, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Dec 23, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 4, 2025 NPUB
PUBLISHED FOR OPPOSITION
Nov 4, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Oct 29, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 7, 2025 CNSA
REFUSAL PROCESSED BY IB
Sep 5, 2025 RFNT
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2025 TROA
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Aug 15, 2025 RFCS
REFUSAL PROCESSED BY MPU
Aug 14, 2025 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Aug 8, 2025 RFCR
NON-FINAL ACTION WRITTEN
Aug 7, 2025 CNRT
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
Dec 29, 2024 RFWR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Dec 13, 2024 RFCR
NON-FINAL ACTION WRITTEN
Dec 12, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 6, 2024 DOCK
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sep 19, 2024 ECDR
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sep 19, 2024 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sep 19, 2024 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sep 19, 2024 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Sep 19, 2024 COAR
APPLICATION FILING RECEIPT MAILED
Sep 16, 2024 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 16, 2024 NWOS
LIMITATION FROM ORIGINAL APPLICATION ENTERED
Sep 3, 2024 LIMI
SN ASSIGNED FOR SECT 66A APPL FROM IB
Aug 29, 2024 REPR